Article info
PDFCritical care
Original article
Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis
- Correspondence to Professor A John Simpson, Institute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; j.simpson{at}ncl.ac.uk
Citation
Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis
Publication history
- Received November 23, 2017
- Revised April 10, 2018
- Accepted April 23, 2018
- First published July 31, 2018.
Online issue publication
September 01, 2022
Article Versions
- Previous version (25 May 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/